We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Gives Generic-Drug Makers a QbD Example for Modified-Release Drugs
FDA Gives Generic-Drug Makers a QbD Example for Modified-Release Drugs
January 11, 2012
The FDA is encouraging generic-drug makers to use quality by design (QbD) for modified-release products by publishing an example of the development, design and manufacturing of a fictitious modified-release drug using QbD principles.